Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 818 results for "gilead sciences"

Gilead Sciences (GILD) Stock Declines on Lawsuit Seeking Access to Clinical Trial Data

Gilead Sciences (GILD) Stock Declines on Lawsuit Seeking Acces...

Reddit Email Print Reprint NEW YORK ( TheStreet ) -- Gilead Sciences ( GILD - Get Report ) shares are down 2.6% to $116.40 in afternoon trading on Monday after the Food and Drug Administration was sued by two health groups looking to force ..., 21 hours ago

280 images for gilead sciences

Bidness Etc, 6 days ago
Free-i-News, 2 days ago
American Banking News - Forex, 2 weeks ago
Drug Discovery and Development, 1 week ago
Daily Caller, 1 week ago
Guru Focus, 4 hours ago, 2 days ago
Nasdaq, 2 hours ago, 21 hours ago
USA Today, 5 days ago
Yahoo! Finance

Gilead Sciences, Inc. Continues To See Short Sellers Retreat

Bidness Etc details the biggest changes in short interest data reported as of June 15, in the biotech industry. The companies discussed below are Amgen, Inc. ( NASDAQ:AMGN ), Gilead Sciences, Inc. ( NASDAQ:GILD ), and Illumina, Inc. ( NASDAQ:ILMN ).
 Bidness Etc3 hours ago Biotech Short-Sellers Prefer Amgen To Gilead Sciences  Benzinga.com2 days ago Gilead Sciences, Inc., Biogen Inc See Short Interest Decline; Biotech Bubble More Visible Than Ever  Bidness Etc2 weeks ago Short Sellers Get More Selective on Big Biotech  24/7 Wall St5 days ago

Gilead Sciences Falls 3.38% on Heavy Volume: Watch For Potential Rebound

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $115.30 to a high of $119.14. Yesterday, the shares fell 3.4%, which took the trading range below the 3-day low of $118.89 on volume of 12.4 million shares. ...
 Individual.com19 hours ago Look for Shares of Gilead Sciences to Potentially Rebound after Yesterday's 3.38% Sell Off  PredictWallStreet19 hours ago SmarTrend Watching for Potential Pullback in Shares of Gilead Sciences After 1.41% Gain  Individual.com1 week ago Gilead Sciences Set to Possibly Pullback After Yesterday's Rally of 1.41%  TradingCharts.com1 week ago

Gilead Sciences (GILD): An Ideal Buy the Dip Candidate

GILD has been on a tear over the last couple of months as you can see, rising from around $100 to a high of over $123 in about six weeks. That high was last week, but in the last three trading days the stock has retraced around 6.5 percent. If ...
 Nasdaq3 hours ago Gilead Sciences Shares Up 14.4% Since SmarTrend's Buy Recommendation (GILD)  Individual.com4 days ago Gilead Sciences Up 13.8% Since SmarTrend Uptrend Call (GILD)  Individual.com1 week ago
Guru Focus

Why I Am Buying Gilead Sciences

 Guru Focus4 hours ago Continue Buying Gilead Sciences At Current Prices  Seeking Alpha5 days ago

Gilead Sciences (GILD) Showing Bullish Technicals With Support At $117.95

The option-trade picking algorithms behind's Artifical Intelligence Center have selected a covered-call trade on Gilead Sciences Inc ("GILD) that includes 3.81% downside ...
 Individual.com1 day ago Gilead Sciences (GILD) Showing Resistance Near $124.06  TradingCharts.com4 days ago

Gilead Sciences (GILD) Approaches New Downside Target of $118.08

Shares of Gilead Sciences (NASDAQ:GILD) opened today below their pivot of $120.88 and have already reached the first level of support at $119.16. Investors may be interested in a cross of the next downside pivot targets of $118.08
 Individual.com3 days ago Watch for Shares of Gilead Sciences (GILD) to Approach Resistance at $121.57  TradingCharts.com1 week ago Watch for Continued Gains in Shares of Gilead Sciences (GILD)  Individual.com6 days ago Gilead Sciences Looks to Continue to Trade Above its Annual-High Share Price Today  Individual.com1 week ago
Investor's Business Daily

Acquisitions May Fuel Gilead Sciences' Winning Ways

G ilead Sciences has been on a winning streak in recent years. But competition and price pressure may push the biotech pace-setter to go for acquisitions to continue the momentum. Gilead 's (NASDAQ: GILD ) Q1 revenue climbed 52 percent from the ...
 Investor's Business Daily3 days ago

Next Support Level for Gilead Sciences (GILD) is $118.08

Shares of Gilead Sciences (NASDAQ:GILD) have bearishly opened below the pivot of $120.88 today and have reached the first support level of $119.16. Investors may be interested in a cross of the next downside pivot targets of $118.08
 Individual.com3 days ago

Gilead: Still My Next Apple

I have been receiving a lot of questions around Gilead Sciences (NASDAQ:GILD) over the past few weeks, as the biotech juggernaut has finally broken out of a relatively tight trading range it had been stuck in for a couple of quarters. This makes ...
 Seeking Alpha4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gilead sciences
Get updated on latest news & your favorite topics right in your inbox!
More     Less